The Indian drug regulatory agency Central Drugs Standard Control Organization (CDSCO) announced on March 4 that drug products imported into India must comply with Indian requirements for the manufacture of medicinal products.

CDSCO has increased surveillance of medical products imported into India in an effort to safeguard public health and to help ensure product efficacy and safety.  In an official announcement, the CDSCO stated “It has been decided that the drugs for import into the country shall be allowed only if these are in compliance to the requirements of the Drugs & Cosmetics Act, 1940 and Drugs & Cosmetics Rules, 1945.”  Compliance may be demonstrated through product testing and/or independent audits of manufacturing facilities prior to import.